FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091068 [Registered on: 17/07/2025] Trial Registered Prospectively
Last Modified On: 16/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Biological
Dentistry 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   comparing the result of blood product with or without antibiotics in the treatment of gum disease. 
Scientific Title of Study   "A Comparative Evaluation of Injectable Platelet-Rich Fibrin (i-PRF) With and Without Amoxicillin in the Treatment of Chronic Periodontitis: A Randomized Controlled Trial" 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Priyanka Yadav 
Designation  Academic junior resident 
Affiliation  faculty of dental sciences IMS, BHU 
Address  Room no 5, 3rd floor, department of periodontology,faculty of dental sciences,trauma centre, BHU varansasi, uttar pradesh
Room no 5, 3rd floor, department of periodontology,faculty of dental sciences,trauma centre, BHU varansasi, uttar pradesh pin code 221005
Gorakhpur
UTTAR PRADESH
273209
India 
Phone  09935473940  
Fax    
Email  yadavpriyanka70299@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Anju Gautam 
Designation  Professor 
Affiliation  faculty of dental sciences IMS, BHU 
Address  Room no 5, 3rd floor, department of periodontology,faculty of dental sciences,trauma centre, BHU varansasi, uttar pradesh pin code 221005

Varanasi
UTTAR PRADESH
221005
India 
Phone  8299867542  
Fax    
Email  dranjugautam@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Priyanka Yadav 
Designation  Academic junior resident 
Affiliation  Faculty of dental sciences IMS, BHU 
Address  Room no 5, 3rd floor, department of periodontology,faculty of dental sciences,trauma centre, BHU varansasi, uttar pradesh
Room no 5, 3rd floor, department of periodontology,faculty of dental sciences,trauma centre, BHU varansasi, uttar pradesh pin code 221005
Varanasi
UTTAR PRADESH
221005
India 
Phone  09935473940  
Fax    
Email  yadavpriyanka70299@gmail.com  
 
Source of Monetary or Material Support  
Department of periodontology, faculty of dental sciences, IMS, BHU, varanasi , uttar pradesh, India, pin code 221005 
 
Primary Sponsor  
Name  Priyanka yadav 
Address  nagarjuna girls hostel, BHU campus, varanasi, Uttar pradesh. India ,pin code 221005 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr PRIYANKA YADAV  Faculty of dental sciences IMS, BHU  Room no 5, 3rd floor, department of periodontology, faculty of dental sciences, trauma centre BHU, Varanasi, pin 221005
Varanasi
UTTAR PRADESH 
09935473940

yadavpriyanka70299@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee IMS, BHU varanasi uttar pradesh, 221005 india   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: K053||Chronic periodontitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Amoxicillin-Loaded Injectable Platelet-Rich Fibrin (i-PRF)  900 µL of i-PRF will be mixed with 100 µL of freshly prepared amoxicillin solution (stock concentration: 5 mg/mL) to achieve a final concentration of 0.5 mg/mL. This amoxicillin-incorporated i-PRF will be then transferred into sterile 1 mL insulin syringes (30G). The prepared mixture is then injected locally into each selected periodontal pocket (with more than 5 mm probing depth), with 0.2 mL deposited subgingivally and an additional 0.1 mL injected intramucosal at the papillary region.  
Comparator Agent  Injectable platelet rich fibrin  10 mL of autologous venous blood will be drawn from each participant under aseptic conditions into sterile, non-coated vacuum tubes (without anticoagulants). The blood sample will be then centrifuged using a horizontal centrifuge at 700 rpm for 3 minutes, following the low-speed centrifugation concept (LSCC). The upper fluid layer containing i-PRF is carefully aspirated within 60 seconds to maintain its liquid phase. The i-PRF is then loaded into sterile 1 mL syringes and injected subgingivally (approximately 0.2 mL per pocket) into periodontal pockets with depths more than 5 mm, and 0.1 mL will be injected into each adjacent interdental papilla. 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1.Patient diagnosed with chronic periodontitis o Patients having periodontal pockets of more than 5 mm
2. Patient with clinical attachment loss more than 2 mm
3.Age group between 25- 50 years.
4. Patients with good general health, without any history of systemic disease or under medication
5. Patient ready to give written informed consent.

 
 
ExclusionCriteria 
Details  1. Medically compromised patient. o Patient on antimicrobial therapy
2. Smokers and smokeless tobacco users.
3. Patients showing unacceptable oral hygiene during evaluation.
4. Patient who received periodontal therapy in the past 6 months.
5.Pregnant women and lactating mothers
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Not Applicable 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of amoxicillin incorporated I-PRF as local drug delivery for the treatment.   At base line, 1month, 3month  
 
Secondary Outcome  
Outcome  TimePoints 
I.Assessment of gingival index and plaque index before and after placement of amoxicillin incorporated I-PRF as local drug delivery.
II.Assessment of periodontal pocket depth (PPD) and clinical attachment index (CAL) before and after index before and after placement of amoxicillin incorporate I-PRF .
III.To compare the effect of amoxicillin incorporated I-PRF with I-PRF alone as Local drug Delivery.

 
At base line,1week,3week, 1month, 3month  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   19/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   To achieve the desirable accomplishments, there we are attempting to evaluate the clinical efficacy of injectable Platelet-Rich Fibrin (i-PRF) with and without amoxicillin as an adjunct to scaling and root planing (SRP) in the management of chronic periodontitis. A total of eligible participants will be randomly allocated into two groups: the test group will receive SRP followed by subgingival injection of amoxicillin-loaded i-PRF, while the control group will receive SRP followed by injection of drug-free i-PRF. i-PRF is prepared from autologous blood using a low-speed centrifugation protocol and injected into periodontal pockets more than 5 mm and adjacent interdental papillae in a single treatment session. The study aims to assess and compare clinical periodontal parameters such as probing pocket depth (PPD), clinical attachment level (CAL), bleeding on probing (BOP), and plaque index (PI) at baseline and subsequent follow-ups. The objective is to determine whether the addition of amoxicillin to i-PRF enhances periodontal healing outcomes compared to i-PRF alone. 
Close